Lanlan Li

2.8k total citations
71 papers, 2.2k citations indexed

About

Lanlan Li is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Lanlan Li has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Biomedical Engineering and 12 papers in Immunology. Recurrent topics in Lanlan Li's work include Nanoplatforms for cancer theranostics (12 papers), Extracellular vesicles in disease (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Lanlan Li is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Extracellular vesicles in disease (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Lanlan Li collaborates with scholars based in China, United States and Macao. Lanlan Li's co-authors include Jianxiang Zhang, Yin Dou, Chenwen Li, Jiawei Guo, Hui Tao, Houyuan Hu, Xiaoqiu Xu, Yi Jia, Huijie An and Wendan Pu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Lanlan Li

67 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Li China 25 718 606 404 366 340 71 2.2k
Bo Wu China 29 824 1.1× 866 1.4× 412 1.0× 520 1.4× 283 0.8× 119 2.7k
Gaofeng Shu China 29 775 1.1× 933 1.5× 509 1.3× 510 1.4× 251 0.7× 68 2.8k
Jin Cao China 30 1.2k 1.7× 957 1.6× 450 1.1× 514 1.4× 222 0.7× 78 3.5k
Jian Liu China 36 1.3k 1.8× 497 0.8× 374 0.9× 303 0.8× 408 1.2× 195 3.4k
Markus Heine Germany 22 831 1.2× 530 0.9× 487 1.2× 567 1.5× 308 0.9× 53 2.8k
Wei Xie China 29 1.2k 1.6× 1.1k 1.7× 417 1.0× 399 1.1× 271 0.8× 78 2.7k
Xin Ji China 29 669 0.9× 817 1.3× 701 1.7× 347 0.9× 141 0.4× 145 3.0k
Xiaoqiu Xu China 19 470 0.7× 612 1.0× 419 1.0× 384 1.0× 216 0.6× 28 1.6k
Markus Rehberg Germany 29 934 1.3× 474 0.8× 678 1.7× 214 0.6× 332 1.0× 59 2.5k

Countries citing papers authored by Lanlan Li

Since Specialization
Citations

This map shows the geographic impact of Lanlan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Li more than expected).

Fields of papers citing papers by Lanlan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Li. The network helps show where Lanlan Li may publish in the future.

Co-authorship network of co-authors of Lanlan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Li. A scholar is included among the top collaborators of Lanlan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Li. Lanlan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Lanlan, Baohua Zhao, Yifei Lü, et al.. (2025). A ROS-responsive nanoprodrug-engineered phage biotherapy for precision treatment of multidrug-resistant Gram-negative bacterial pneumonia. Journal of Controlled Release. 382. 113708–113708. 3 indexed citations
3.
Xu, Hong, Sheng Wang, Qing Zhang, et al.. (2025). Bisphenol A exacerbates colorectal cancer progression through enhancing ceramide synthesis. Toxicology. 511. 154054–154054. 4 indexed citations
4.
Wang, Wenkai, Yan Wang, Peng Wu, et al.. (2024). Pathophysiology‐Directed Engineering of a Combination Nanoanalgesic for Neuropathic Pain. Advanced Science. 12(8). e2405483–e2405483.
5.
Li, Lanlan, et al.. (2024). Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action. Current Pharmaceutical Biotechnology. 25(17). 2186–2199. 5 indexed citations
6.
Yan, Tao, Shan Wu, Jia‐Wei Lin, et al.. (2024). Sanguinarine chloride induces ferroptosis by regulating ROS/BACH1/HMOX1 signaling pathway in prostate cancer. Chinese Medicine. 19(1). 7–7. 17 indexed citations
7.
Wu, Qian, et al.. (2023). Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review. Frontiers in Pharmacology. 14. 1083875–1083875. 13 indexed citations
8.
Li, Juan, et al.. (2023). Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer. Heliyon. 9(2). e13094–e13094. 4 indexed citations
9.
Li, Lanlan, Yi Hu, Pengfei Wang, et al.. (2023). Site-specific inhibition of neutrophilic inflammation by low-dose nanotherapy for immunoregulatory treatment of asthma. Nano Today. 52. 101957–101957. 9 indexed citations
10.
He, Gonghan, Yingping He, Lida Xu, et al.. (2023). La(Ca)CrO3-Filled SiCN Precursor Thin Film Temperature Sensor Capable to Measure up to 1100 °C High Temperature. Micromachines. 14(9). 1719–1719. 7 indexed citations
11.
Du, Yan, et al.. (2023). Targeting SDCBP2 in acute myeloid leukemia. Cellular Signalling. 112. 110889–110889.
12.
Wang, Zirui, Yujiao Wang, Lanlan Li, et al.. (2021). Immune Cell Landscape in Gastric Cancer. BioMed Research International. 2021(1). 1930706–1930706. 15 indexed citations
13.
14.
Li, Chenwen, Ying Hu, Shuguang Chen, et al.. (2020). A reactive oxygen species-responsive antioxidant nanotherapy for the treatment of drug-induced tissue and organ injury. Biomaterials Science. 8(24). 7117–7131. 17 indexed citations
15.
Dou, Yin, Chenwen Li, Lanlan Li, Jiawei Guo, & Jianxiang Zhang. (2020). Bioresponsive drug delivery systems for the treatment of inflammatory diseases. Journal of Controlled Release. 327. 641–666. 153 indexed citations
16.
17.
Zhang, Xiangjun, Qiaoxian Huang, Xiaoqiu Xu, et al.. (2019). An Eco- and User-Friendly Herbicide. Journal of Agricultural and Food Chemistry. 67(28). 7783–7792. 27 indexed citations
18.
Zhang, Xiangjun, Qian Cheng, Lanlan Li, et al.. (2019). Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent. Theranostics. 9(11). 3107–3121. 47 indexed citations
19.
Zhang, Qiuli, Wei Wang, Yan Jiang, et al.. (2018). GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway. Biomedicine & Pharmacotherapy. 101. 494–500. 19 indexed citations
20.
Li, Lanlan, et al.. (2006). Advances in Study of Chemical Constituents and Pharmacological Effect of Phyllanthus Urinaria L.Against HBV. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Wu Breakdown of academic impact, for papers by Gaofeng Shu Breakdown of academic impact, for papers by Jin Cao Breakdown of academic impact, for papers by Jian Liu Breakdown of academic impact, for papers by Markus Heine Breakdown of academic impact, for papers by Wei Xie Breakdown of academic impact, for papers by Xin Ji Breakdown of academic impact, for papers by Xiaoqiu Xu Breakdown of academic impact, for papers by Markus Rehberg
Rankless by CCL
2026